Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1/2 4Phase 1 4Phase 3 3

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4Other hematologic neoplasm 2Myeloid 1

Conditions

Leukemia, Myeloid, Acute 146Leukemia 49Precursor Cell Lymphoblastic Leukemia-Lymphoma 46Congenital Abnormalities 30Myelodysplastic Syndromes 25Leukemia, Monocytic, Acute 23Recurrence 22Leukemia, Myelomonocytic, Acute 22Leukemia, Erythroblastic, Acute 20Leukemia, Megakaryoblastic, Acute 19Lymphoma 17Leukemia, Biphenotypic, Acute 13Lymphoma, Non-Hodgkin 12Burkitt Lymphoma 12Lymphoma, Large B-Cell, Diffuse 11Leukemia, Myelomonocytic, Chronic 11Blast Crisis 11Lymphoma, Mantle-Cell 9Leukemia, Lymphocytic, Chronic, B-Cell 9Lymphoma, Follicular 8Lymphoma, Large-Cell, Immunoblastic 7Leukemia, Eosinophilic, Acute 7Leukemia, Basophilic, Acute 7Myeloproliferative Disorders 6Lymphoma, B-Cell, Marginal Zone 6Hodgkin Disease 6Hematologic Neoplasms 6Myelodysplastic-Myeloproliferative Diseases 5Leukemia, Promyelocytic, Acute 5Leukemia, Myeloid, Accelerated Phase 5

Interventions

Cyclophosphamide 38fludarabine 30Rituximab 26obinutuzumab 10Bendamustine Hydrochloride 10fludarabine phosphate 9pembrolizumab 8Specimen Handling 7Etoposide 7venetoclax 6Vincristine 6Prednisone 6Magnetic Resonance Spectroscopy 6Leukapheresis 6Lenalidomide 6ibrutinib 5Inotuzumab Ozogamicin 5Immunotherapy, Adoptive 5Doxorubicin 5Biopsy 5ublituximab 4tazemetostat 4glofitamab 4Interleukin-2 4Dexamethasone 4Cytarabine 4pomalidomide 3polatuzumab vedotin 3Radiation 3Nivolumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Lymphoma, B-Cell × Cytarabine × Clear all
NCT05476770 2024-12-06

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1 Recruiting
54 enrolled
LymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Hodgkin Disease, Leukemia, Biphenotypic, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00968760 2023-12-19

CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies

M.D. Anderson Cancer Center

Phase 1 Completed
34 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Mantle-Cell

NCT02741388 2021-12-07

SELINDA

The Lymphoma Academic Research Organisation

Phase 1 Completed
39 enrolled
Lymphoid

Lymphoma, Lymphoma, B-Cell

NCT02483000 2020-11-23

Anti-CD20 Radioimmunotherapy Before Chemotherapy and Stem Cell Transplant in Treating Patients With High-Risk B-Cell Malignancies

Fred Hutchinson Cancer Center

Phase 1 Terminated
3 enrolled 12 charts
Lymphoid

Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡